Skip to content

Study of Medication Errors in patients receiving treatment in Operation Theatre and Intensive Care Unit

Evaluation of Medication Errors while Prescribing, Preparing, or Administering drugs in the Operation Theatre and Adult Intensive Care Unit- A Prospective Observational Study.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2026/04/107591
Enrollment
300
Registered
2026-04-06
Start date
Unknown
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Nil: Nil Intervention2: Nil: Nil

Sponsors

ALL INDIAN INSTITUTE OF MEDICAL SCIENCE JODHPUR
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All medications and procedures were administered to adult patients in OT and AICU during the study period.

Exclusion criteria

Exclusion criteria: Pediatric Patients and TPN patients

Design outcomes

Primary

MeasureTime frame
Primary Outcome- To determine the nature and frequency of medication errors while prescribing, preparing, storing the prepared medication or while administering the drugs to the patients in OT and AICU. Timepoint: Data will be collected at the time of drug prescription, preparation and administration during intraoperative period and ICU stay until discharge or transfer, which is 1year 6 months of trial period

Secondary

MeasureTime frame
To study the extent of the medication error in terms of whether the error reached the patient or not. To study the harmful effects of medication errors on the patient. To study the communication of the medication error to the patient or the caregivers. To analyze potential contributing factors such as staffing, workload, & provider characteristics.Timepoint: Data will be collected at the time of drug prescription, preparation & administration during the intraoperative period & ICU stay until discharge or transfer, which is 1year 6 months of trial period

Countries

India

Contacts

Public ContactDR SHILPA GOYAL

ALL INDIA INSTITUTE OF MEDICAL SCIENCES, JODHPUR

drshilpagoyal@yahoo.com8003996880

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: May 1, 2026